Histologic evaluation of allograft biopsies after lung transplantation has several limitations, suggesting that molecular assessment using tissue transcriptomics could improve biopsy interpretation. This single-center, retrospective cohort study evaluated discrepancies between the histology of transbronchial biopsies (TBBs) with no rejection (NR) and T-cell mediated rejection (TCMR) by molecular diagnosis. The accuracy of diagnosis was assessed based on response to treatment. 54 TBBs from Prague Lung Transplant Program obtained between December 2015 and January 2020 were included. Patients with acute cellular rejection (ACR) grade ≥ 1 by histology received anti-rejection treatment. Response to therapy was defined as an increase in FEV1 of ≥ 10% 4 weeks post-biopsy compared to the pre-biopsy value. Among the 54 analyzed TBBs, 25 (46%) were concordant with histology, while 29 (54%) showed discrepancies. ACR grade 0 was found in 12 TBBs (22%) and grade A1 ≥ 1 in 42 TBBs (78%). Treatment response was present in 14% in the NR group and in 50% in the TCMR group (p = 0.024). Our findings suggest that low-grade acute cellular rejection is less likely to be associated with molecular TCMR, which might better identify lung transplant recipients who benefit from therapy.

2nd Faculty of Medicine Charles University Prague Czechia

Alberta Transplant Applied Genomics Centre Edmonton AB Canada

Department of Medicine University of Alberta Edmonton AB Canada

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czechia

Prague Lung Transplant Program 3rd Department of Surgery 1st Faculty of Medicine Charles University Motol University Hospital Prague Czechia

Prague Lung Transplant Program Department of Pneumology 2nd Faculty of Medicine Charles University Motol University Hospital Prague Czechia

Zobrazit více v PubMed

Chambers DC, Cherikh WS, Harhay MO, Hayes D, Jr, Hsich E, Khush KK, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Sixth Adult Lung and Heart-Lung Transplantation Report-2019; Focus Theme: Donor and Recipient Size Match. J Heart Lung Transpl (2019) 38(10):1042–55. 10.1016/j.healun.2019.08.001 PubMed DOI PMC

Sun H, Deng M, Chen W, Liu M, Dai H, Wang C. Graft Dysfunction and Rejection of Lung Transplant, a Review on Diagnosis and Management. Clin Respir J (2022) 16(1):5–12. 10.1111/crj.13471 PubMed DOI PMC

Levy L, Huszti E, Tikkanen J, Ghany R, Klement W, Ahmed M, et al. The Impact of First Untreated Subclinical Minimal Acute Rejection on Risk for Chronic Lung Allograft Dysfunction or Death After Lung Transplantation. Am J Transpl (2020) 20(1):241–9. 10.1111/ajt.15561 PubMed DOI

Arcasoy SM, Berry G, Marboe CC, Tazelaar HD, Zamora MR, Wolters HJ, et al. Pathologic Interpretation of Transbronchial Biopsy for Acute Rejection of Lung Allograft Is Highly Variable. Am J Transpl (2011) 11(2):320–8. 10.1111/j.1600-6143.2010.03382.x PubMed DOI

Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute Allograft Rejection: Cellular and Humoral Processes. Clin Chest Med (2011) 32(2):295–310. 10.1016/j.ccm.2011.02.008 PubMed DOI PMC

Halloran KM, Parkes MD, Chang J, Timofte IL, Snell GI, Westall GP, et al. Molecular Assessment of Rejection and Injury in Lung Transplant Biopsies. J Heart Lung Transpl (2019) 38(5):504–13. 10.1016/j.healun.2019.01.1317 PubMed DOI

Halloran K, Parkes MD, Timofte I, Snell G, Westall G, Havlin J, et al. Molecular T-Cell‒mediated Rejection in Transbronchial and Mucosal Lung Transplant Biopsies Is Associated With Future Risk of Graft Loss. J Heart Lung Transpl (2020) 39(12):1327–37. 10.1016/j.healun.2020.08.013 PubMed DOI

Pradère P, Zajacova A, Bos S, Le Pavec J, Fisher A. Molecular Monitoring of Lung Allograft Health: Is It Ready for Routine Clinical Use? Eur Respir Rev (2023) 32(170):230125. 10.1183/16000617.0125-2023 PubMed DOI PMC

Naesens M, Roufosse C, Haas M, Lefaucheur C, Mannon RB, Adam BA, et al. The Banff 2022 Kidney Meeting Report: Reappraisal of Microvascular Inflammation and the Role of Biopsy-Based Transcript Diagnostics. Am J Transpl (2024) 24:338–49. 10.1016/j.ajt.2023.10.016 PubMed DOI

Mehlman Y, Valledor AF, Moeller C, Rubinstein G, Lotan D, Rahman S, et al. The Utilization of Molecular Microscope in Management of Heart Transplant Recipients in the Era of Noninvasive Monitoring. Clin Transpl (2023) 37(12):e15131. 10.1111/ctr.15131 PubMed DOI

Halloran K, Parkes MD, Timofte IL, Snell GI, Westall GP, Hachem R, et al. Molecular Phenotyping of Rejection-Related Changes in Mucosal Biopsies From Lung Transplants. Am J Transpl (2020) 20(4):954–66. 10.1111/ajt.15685 PubMed DOI

Gauthier PT, Mackova M, Hirji A, Weinkauf J, Timofte IL, Snell GI, et al. Defining a Natural Killer Cell-Enriched Molecular Rejection-Like State in Lung Transplant Transbronchial Biopsies. Am J Transpl (2023) 23(12):1922–38. 10.1016/j.ajt.2023.06.003 PubMed DOI

Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, et al. Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung Rejection. J Heart Lung Transpl (2007) 26(12):1229–42. 10.1016/j.healun.2007.10.017 PubMed DOI

Halloran PF, Madill-Thomsen KS, Reeve J. The Molecular Phenotype of Kidney Transplants: Insights From the MMDx Project. Transplantation (2024) 108(1):45–71. 10.1097/TP.0000000000004624 PubMed DOI PMC

Reeve J, Sellarés J, Mengel M, Sis B, Skene A, Hidalgo L, et al. Molecular Diagnosis of T Cell-Mediated Rejection in Human Kidney Transplant Biopsies. Am J Transpl (2013) 13(3):645–55. 10.1111/ajt.12079 PubMed DOI

Madill-Thomsen KS, Wiggins RC, Eskandary F, Böhmig GA, Halloran PF. The Effect of Cortex/Medulla Proportions on Molecular Diagnoses in Kidney Transplant Biopsies: Rejection and Injury Can Be Assessed in Medulla. Am J Transpl (2017) 17(8):2117–28. 10.1111/ajt.14233 PubMed DOI PMC

Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Billings P, et al. The Trifecta Study: Comparing Plasma Levels of Donor-Derived Cell-Free DNA With the Molecular Phenotype of Kidney Transplant Biopsies. J Am Soc Nephrol (2022) 33(2):387–400. 10.1681/ASN.2021091191 PubMed DOI PMC

Gupta G, Moinuddin I, Kamal L, King AL, Winstead R, Demehin M, et al. Correlation of Donor-Derived Cell-Free DNA With Histology and Molecular Diagnoses of Kidney Transplant Biopsies. Transplantation (2022) 106(5):1061–70. 10.1097/TP.0000000000003838 PubMed DOI

Schachtner T, von Moos S, Kokkonen SM, Helmchen B, Gaspert A, Mackova M, et al. The Molecular Diagnosis Might Be Clinically Useful in Discrepant Kidney Allograft Biopsy Findings: An Analysis of Clinical Outcomes. Transplantation (2023) 107(2):485–94. 10.1097/TP.0000000000004284 PubMed DOI PMC